Informationen:
Fehler:
ID
16304
Beschreibung
Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00409071
Link
https://clinicaltrials.gov/show/NCT00409071
Stichworte
Versionen (1)
- 10.07.16 10.07.16 -
Hochgeladen am
10. Juli 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Cancer NCT00409071
Eligibility Breast Cancer NCT00409071
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Cancer NCT00409071
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
women with non metastatic breast cancer
Item
women with histologically proven non metastatic breast cancer
boolean
C0079399 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1300072 (UMLS CUI [1,3])
C0678222 (UMLS CUI [1,2])
C1300072 (UMLS CUI [1,3])
Previous chemotherapy
Item
no previous chemotherapy
boolean
C1514457 (UMLS CUI [1])
treatment planning including 6 adjuvant ct courses
Item
treatment planning including 6 adjuvant ct courses with the first 3 being necessarily of the fac50, fec100 or tac type
boolean
C0085533 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,2])
age
Item
age>= 18 years
boolean
C0001779 (UMLS CUI [1])
ECOG
Item
ecog performance status (ps) <= 2 (who scale)
boolean
C1520224 (UMLS CUI [1])
language
Item
patient able to read and understand french
boolean
C1145677 (UMLS CUI [1])
Informed Consent
Item
written, voluntary, informed consent
boolean
C0021430 (UMLS CUI [1])
previous treatment with chemotherapy
Item
previous treatment with chemotherapy (including neo-adjuvant chemotherapy for breast cancer)
boolean
C1514457 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
previous malignancies
Item
previous malignancies (except basal cell skin cancer or cervical cancer in situ or any other curatively treated malignancy in complete remission for more than 5 years)
boolean
C0006826 (UMLS CUI [1])
contraindication to corticosteroids or 5-ht3 receptor antagonists
Item
contraindication to corticosteroids or 5-ht3 receptor antagonists
boolean
C1301624 (UMLS CUI [1,1])
C0001617 (UMLS CUI [1,2])
C2936526 (UMLS CUI [1,3])
C0001617 (UMLS CUI [1,2])
C2936526 (UMLS CUI [1,3])
treatment with anti-emetic drugs
Item
treatment with cocculine® or any other anti-emetic drug in the 15 days before inclusion
boolean
C0003297 (UMLS CUI [1])
pregnant or lactating women
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
follow-up
Item
follow-up impossible for social, geographical, familial or psychological reasons
boolean
C1522577 (UMLS CUI [1])
Telephone
Item
patients who cannot be contacted by phone
boolean
C0039457 (UMLS CUI [1])